Get the top three things to know in women's health + wellness, every weekday:

FDA Commits to Reviewing Abortion Drug Mifepristone

What: FDA Commissioner Marty Makary sent a letter to Sen. Josh Hawley (R-Mo.) promising to investigate the abortion pill mifepristone. The letter was prompted by Sen. Hawley sending a conservative think tank’s “study” on abortion pill risks, which experts have dismissed for using wildly flawed methods. Makary’s response did not include any specific plans for the review.

Key Line: “The study does not clearly state the database… The research breaks down the ‘serious adverse events’ by category but places the majority of those events into a vague category called ‘other abortion-specific complications.'”

Source: The Hill

More News Snippets
MAHA, Mitochondria, and Money

The Atlantic explains the MAHA movement’s mysterious focus on the mitochondria, a tiny structure in cells that generate energy.

MAHA, Mitochondria, and Money

The Atlantic explains the MAHA movement’s mysterious focus on the mitochondria, a tiny structure in cells that generate energy.

Anorexia As Women Age

The New York Times profiles older women struggling with anorexia, with limited treatment options and serious long-term health consequences.